Daiwa Securities Group Inc. G1 Therapeutics, Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$13.16 - $22.47 $960 - $1,640	73 Added 101.39%	145 $2,000
Q4 2020 Feb 04, 2021	SELL	$10.99 - $20.4 $1,538 - $2,856	-140 Reduced 66.04%	72 $1,000
Q4 2019 Jan 31, 2020	SELL	$20.54 - $31.0 $534 - $806	-26 Reduced 10.92%	212 $6,000
Q1 2019 Apr 26, 2019	BUY	$14.4 - $21.45 $1,166 - $1,737	81 Added 51.59%	238 $4,000
Q1 2018 May 02, 2018	BUY	$19.05 - $41.76 $2,990 - $6,556	157 New	157 $6,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.